Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer
- First Posted Date
- 2015-12-15
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 65
- Registration Number
- NCT02630199
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Korea, Republic of
Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis
Phase 2
Completed
- Conditions
- Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
- Interventions
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 62
- Registration Number
- NCT02628951
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor
- First Posted Date
- 2015-11-18
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT02607631
EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors
Not Applicable
Completed
- Conditions
- Alopecia
- Interventions
- Other: PlaceboOther: CG428
- First Posted Date
- 2015-11-16
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT02605629
- Locations
- 🇰🇷
Danbee Kang, Seoul, Korea, Republic of
REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)
- Conditions
- Acute Coronary Syndromes
- Interventions
- Device: Bioresorbable scaffold (BRS)
- First Posted Date
- 2015-11-10
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT02601404
- Locations
- 🇰🇷
Cardiac and Vascular Center; Samsung Medical Center, Seoul, Korea, Republic of
The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients
Phase 2
- Conditions
- AnemiaCancer
- Interventions
- Drug: Ferinject®
- First Posted Date
- 2015-11-06
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT02599012
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Irwon-ro ,Kangnam-gu, Korea, Republic of
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 350
- Registration Number
- NCT02597179
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-Gu, Korea, Republic of
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
- Conditions
- Metastatic Cancer
- First Posted Date
- 2015-11-01
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT02593578
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2015-11-01
- Last Posted Date
- 2019-12-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02593591
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Seoul, Korea, Republic Of, Korea, Republic of
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
Phase 2
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 182
- Registration Number
- NCT02592746
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath